TScan Therapeutics, Inc. (TCRX) SEC filings
TCRX SEC filings moved a median of -2.46% by the close. TCRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the TCRX overview →
69 measured TCRX SEC filing events.
Where these TCRX SEC filings landedvs 67 measured TCRX SEC filing reactions
| Middle 50% of TCRX SEC filing reactions | -6.01% to +4.24% |
|---|---|
| Median reaction (to close) | -2.46% |
| Measured reactions | 67 |
Point-in-time · zero look-ahead
Half of the 67 TCRX SEC filing events with a measured close landed between -6.01% and +4.24%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K TScan Therapeutics, Inc. For: Oct 13 | SEC filing · Form 8-K | -3.70% | -11.61% | |
| Form PRE 14A TScan Therapeutics, Inc. For: Nov 20 | SEC filing · Form PRE | -3.70% | -11.61% | |
| Form 8-K TScan Therapeutics, Inc. For: Sep 24 | SEC filing · Form 8-K | +0.38% | -0.47% | |
| Form 8-K TScan Therapeutics, Inc. For: Sep 08 | SEC filing · Form 8-K | -1.29% | -1.17% | |
| Form 8-K TScan Therapeutics, Inc. For: Aug 27 | SEC filing · Form 8-K | -9.98% | -30.71% | |
| Form 8-K TScan Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +5.51% | -2.60% | |
| Form 10-Q TScan Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.92% | -2.28% | |
| Form 8-K TScan Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | -3.92% | -2.28% | |
| Form 8-K TScan Therapeutics, Inc. For: Jun 22 | SEC filing · Form 8-K | -1.28% | -7.23% | |
| Form 8-K TScan Therapeutics, Inc. For: May 20 | SEC filing · Form 8-K | -0.94% | +1.91% | |
| Form 10-Q TScan Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.94% | +5.04% | |
| Form 8-K TScan Therapeutics, Inc. For: May 06 | SEC filing · Form 8-K | +2.94% | +5.04% | |
| Form ARS TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +2.23% | +6.25% | |
| Form DEF 14A TScan Therapeutics, Inc. For: May 20 | SEC filing · Form DEF | +2.23% | +6.25% | |
| Form PRE 14A TScan Therapeutics, Inc. For: May 20 | SEC filing · Form PRE | -3.91% | -7.83% | |
| Form 8-K TScan Therapeutics, Inc. For: Mar 31 | SEC filing · Form 8-K | +2.00% | +1.00% | |
| Form 10-K TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.91% | +2.86% | |
| Form 8-K TScan Therapeutics, Inc. For: Mar 04 | SEC filing · Form 8-K | -1.91% | +2.86% | |
| Form S-8 TScan Therapeutics, Inc. | SEC filing · Form S-8 | -1.91% | +2.86% | |
| Form 8-K TScan Therapeutics, Inc. For: Jan 12 | SEC filing · Form 8-K | -0.50% | -3.31% | |
| Form 8-K TScan Therapeutics, Inc. For: Nov 25 | SEC filing · Form 8-K | -5.88% | -6.72% | |
| Form 10-Q TScan Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.01% | -2.46% | |
| Form 8-K TScan Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | -0.01% | -2.46% | |
| Form 8-K TScan Therapeutics, Inc. For: Nov 03 | SEC filing · Form 8-K | -9.46% | -16.22% | |
| Form 8-K TScan Therapeutics, Inc. For: Sep 09 | SEC filing · Form 8-K | +0.53% | -3.16% | |
| Form 8-K TScan Therapeutics, Inc. For: Aug 14 | SEC filing · Form 8-K | +0.00% | +4.19% | |
| Form 10-Q TScan Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.62% | — | |
| Form 8-K TScan Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | -0.62% | — | |
| Form 8-K TScan Therapeutics, Inc. For: Jun 30 | SEC filing · Form 8-K | +0.34% | +0.69% | |
| Form ARS TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | -3.03% | |
| Form DEF 14A TScan Therapeutics, Inc. For: Jun 30 | SEC filing · Form DEF | +0.00% | -3.03% | |
| Form DEFA14A TScan Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | -3.03% | |
| Form 10-Q TScan Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.91% | -7.48% | |
| Form 8-K TScan Therapeutics, Inc. For: May 06 | SEC filing · Form 8-K | -1.91% | -7.48% | |
| Form EFFECT TScan Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -10.92% | |
| Form 10-K TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | -1.70% | -5.88% | |
| Form 8-K TScan Therapeutics, Inc. For: Mar 05 | SEC filing · Form 8-K | -1.70% | -5.88% | |
| Form S-3 TScan Therapeutics, Inc. | SEC filing · Form S-3 | +0.62% | +12.43% | |
| Form S-8 TScan Therapeutics, Inc. | SEC filing · Form S-8 | +0.62% | +12.43% | |
| Form 8-K TScan Therapeutics, Inc. For: Dec 26 | SEC filing · Form 8-K | -7.14% | -9.33% | |
| Form 8-K TScan Therapeutics, Inc. For: Dec 20 | SEC filing · Form 8-K | -3.87% | -2.90% | |
| Form 8-K TScan Therapeutics, Inc. For: Dec 09 | SEC filing · Form 8-K | -7.99% | -29.30% | |
| Form 8-K TScan Therapeutics, Inc. For: Nov 15 | SEC filing · Form 8-K | +0.00% | -4.60% | |
| Form 10-Q TScan Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -0.26% | -5.33% | |
| Form 8-K TScan Therapeutics, Inc. For: Nov 12 | SEC filing · Form 8-K | +0.26% | -4.83% | |
| Form 8-K TScan Therapeutics, Inc. For: Oct 28 | SEC filing · Form 8-K | -1.30% | +7.38% | |
| Form 10-Q TScan Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.95% | +6.57% | |
| Form 8-K TScan Therapeutics, Inc. For: Aug 12 | SEC filing · Form 8-K | +1.95% | +6.57% | |
| Form 8-K TScan Therapeutics, Inc. For: Jun 12 | SEC filing · Form 8-K | +1.12% | -6.14% | |
| Form S-8 TScan Therapeutics, Inc. | SEC filing · Form S-8 | -0.24% | -10.90% | |
| Form 10-Q TScan Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.98% | +4.30% | |
| Form 8-K TScan Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | +0.98% | +4.30% | |
| Form ARS TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | +0.00% | +11.23% | |
| Form DEF 14A TScan Therapeutics, Inc. For: Jun 12 | SEC filing · Form DEF | +0.00% | +11.23% | |
| Form DEFA14A TScan Therapeutics, Inc. | SEC filing · Form DEFA14A | +0.00% | +11.23% | |
| Form 8-K TScan Therapeutics, Inc. For: Apr 16 | SEC filing · Form 8-K | +0.41% | -7.15% | |
| Form 8-K TScan Therapeutics, Inc. For: Apr 16 | SEC filing · Form 8-K | +0.41% | -7.15% | |
| Form EFFECT TScan Therapeutics, Inc. | SEC filing · Form EFFECT | +2.67% | +2.67% | |
| Form 10-K/A TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -0.82% | |
| Form 8-K TScan Therapeutics, Inc. For: Apr 08 | SEC filing · Form 8-K | -0.97% | +1.66% | |
| Form 10-K TScan Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.15% | |
| Form 8-K TScan Therapeutics, Inc. For: Mar 06 | SEC filing · Form 8-K | +0.00% | +5.15% | |
| Form S-3 TScan Therapeutics, Inc. | SEC filing · Form S-3 | -1.09% | -2.86% | |
| Form S-8 TScan Therapeutics, Inc. | SEC filing · Form S-8 | -1.09% | -2.86% | |
| Form 8-K TScan Therapeutics, Inc. For: Jan 24 | SEC filing · Form 8-K | +3.53% | +5.64% | |
| Form 8-K TScan Therapeutics, Inc. For: Dec 09 | SEC filing · Form 8-K | -0.26% | -14.86% | |
| Form 8-K TScan Therapeutics, Inc. For: Dec 06 | SEC filing · Form 8-K | +0.00% | -3.74% | |
| Form 10-Q TScan Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.57% | +3.61% | |
| Form 8-K TScan Therapeutics, Inc. For: Nov 09 | SEC filing · Form 8-K | +4.57% | +3.61% |
Keep exploring
More TCRX: earnings → · analyst actions → · TCRX overview →